130 related articles for article (PubMed ID: 1775633)
1. Stimulation of prostaglandin D2 receptors on human platelets by analogs of prostacyclin.
Alvarez R; Eglen RM; Chang LF; Bruno JJ; Artis DR; Kluge AF; Whiting RL
Prostaglandins; 1991 Aug; 42(2):105-19. PubMed ID: 1775633
[TBL] [Abstract][Full Text] [Related]
2. The antagonism by BW A868C of PGD2 and BW245C activation of human platelet adenylate cyclase.
Trist DG; Collins BA; Wood J; Kelly MG; Robertson AD
Br J Pharmacol; 1989 Feb; 96(2):301-6. PubMed ID: 2466517
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of human platelets and polymorphonuclear neutrophils by the potent and metabolically stable prostaglandin D2 analog ZK 118.182.
Darius H; Michael-Hepp J; Thierauch KH; Fisch A
Eur J Pharmacol; 1994 Jun; 258(3):207-13. PubMed ID: 7522176
[TBL] [Abstract][Full Text] [Related]
4. Specificity between the anti-aggregatory actions of prostacyclin, prostaglandin E1 and D2 on platelets.
Whittle BJ; Hamid S; Lidbury P; Rosam AC
Adv Exp Med Biol; 1985; 192():109-25. PubMed ID: 2871707
[No Abstract] [Full Text] [Related]
5. SQ-27986 inhibition of platelet aggregation is mediated through activation of platelet prostaglandin D2 receptors.
Seiler S; Brassard CL; Federici ME
Prostaglandins; 1990 Aug; 40(2):119-30. PubMed ID: 2171039
[TBL] [Abstract][Full Text] [Related]
6. The classification of prostaglandin DP-receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist.
Giles H; Leff P; Bolofo ML; Kelly MG; Robertson AD
Br J Pharmacol; 1989 Feb; 96(2):291-300. PubMed ID: 2924081
[TBL] [Abstract][Full Text] [Related]
7. (5Z)-carbacyclin discriminates between prostacyclin-receptors coupled to adenylate cyclase in vascular smooth muscle and platelets.
Corsini A; Folco GC; Fumagalli R; Nicosia S; Noe MA; Oliva D
Br J Pharmacol; 1987 Jan; 90(1):255-61. PubMed ID: 3545351
[TBL] [Abstract][Full Text] [Related]
8. Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor.
Merritt JE; Hallam TJ; Brown AM; Boyfield I; Cooper DG; Hickey DM; Jaxa-Chamiec AA; Kaumann AJ; Keen M; Kelly E
Br J Pharmacol; 1991 Jan; 102(1):251-9. PubMed ID: 1710526
[TBL] [Abstract][Full Text] [Related]
9. Octimibate inhibition of platelet aggregation: stimulation of adenylate cyclase through prostacyclin receptor activation.
Seiler S; Brassard CL; Arnold AJ; Meanwell NA; Fleming JS; Keely SL
J Pharmacol Exp Ther; 1990 Dec; 255(3):1021-6. PubMed ID: 2175792
[TBL] [Abstract][Full Text] [Related]
10. Prostacyclin stimulation of the activation of blood coagulation factor X by platelets.
Dutta-Roy AK; Ray TK; Sinha AK
Science; 1986 Jan; 231(4736):385-8. PubMed ID: 3001935
[TBL] [Abstract][Full Text] [Related]
11. The binding of 6-oxo-prostaglandin E1 to platelet prostanoid receptors.
Jaschonek K; Renn W; Weisenberger H
Prostaglandins Leukot Med; 1986 Sep; 24(1):79-86. PubMed ID: 3020591
[TBL] [Abstract][Full Text] [Related]
12. Antagonism of PGD2 vasodepressor responses in the rat in vivo by the novel, selective antagonist, BW A868C.
Hamid-Bloomfield S; Whittle BJ
Br J Pharmacol; 1989 Feb; 96(2):307-12. PubMed ID: 2647205
[TBL] [Abstract][Full Text] [Related]
13. Interaction of prostaglandin D2 with prostacyclin, carbacyclin and the hydantoin prostaglandin, BW245C, in guinea-pig platelets.
Hamid S; Whittle BJ
Br J Pharmacol; 1985 May; 85(1):285-90. PubMed ID: 2992652
[TBL] [Abstract][Full Text] [Related]
14. Synergistic interaction of adenylate cyclase activators and nitric oxide donor SIN-1 on platelet cyclic AMP.
Fisch A; Michael-Hepp J; Meyer J; Darius H
Eur J Pharmacol; 1995 May; 289(3):455-61. PubMed ID: 7556414
[TBL] [Abstract][Full Text] [Related]
15. Refractoriness of platelets to prostaglandins after infusion in rabbits.
Bertelé V; Stemerman M; Schafer A; Adelman B; Smith M; Fuhro R; Salzman E
J Lab Clin Med; 1985 Nov; 106(5):551-61. PubMed ID: 2997353
[TBL] [Abstract][Full Text] [Related]
16. Cytochemical localization of adenylate cyclase in the dense tubule system of human blood platelets stimulated by forskolin, prostacyclin and prostaglandin D2.
Cutler LS; Christian CP; Feinstein MB
Biochim Biophys Acta; 1985 Jun; 845(3):403-10. PubMed ID: 3890960
[TBL] [Abstract][Full Text] [Related]
17. Novel mechanism of heterologous desensitization of adenylate cyclase: prostaglandins bind with different affinities to both stimulatory and inhibitory receptors on platelets.
Ashby B
Mol Pharmacol; 1990 Jul; 38(1):46-53. PubMed ID: 1695318
[TBL] [Abstract][Full Text] [Related]
18. Desacetyl-1-nantradol: a selective prostaglandin antagonist.
Horne WC
Prostaglandins Leukot Med; 1984 Jul; 15(1):129-36. PubMed ID: 6147860
[TBL] [Abstract][Full Text] [Related]
19. The use of stable prostaglandins to investigate prostacyclin (PGI2)-binding sites and PGI2-sensitive adenylate cyclase in human platelet membranes.
Lombroso M; Nicosia S; Paoletti R; Whittle BJ; Moncada S; Vane JR
Prostaglandins; 1984 Feb; 27(2):321-33. PubMed ID: 6326201
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin DP receptors positively coupled to adenylyl cyclase in embryonic bovine tracheal (EBTr) cells: pharmacological characterization using agonists and antagonists.
Crider JY; Griffin BW; Sharif NA
Br J Pharmacol; 1999 May; 127(1):204-10. PubMed ID: 10369474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
